MICHAEL ONEAL: Open Payments
NPI 1114088028 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 24 payments from 10 companies in 2025. Trend: 2023 $410 · 2024 $173 · 2025 $493
Food & beverage: $476Education: $17
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $105 |
| Lilly USA, LLC | 4 | $96 |
| Novo Nordisk Inc | 4 | $66 |
| PFIZER INC. | 3 | $51 |
| Straumann USA LLC | 1 | $49 |
| Insmed, Inc. | 2 | $44 |
| Amgen Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| SANOFI PASTEUR INC. | 1 | $19 |
| Corcept Therapeutics | 1 | $14 |
Products named: FARXIGA, KISUNLA, PREVNAR 20, Ozempic, Arikayce, REPATHA, LEQVIO, MOUNJARO.
Industry payments across FL — which companies pay providers there.
